Samuel Svensson
Algemeen Directeur bij Neogap Therapeutics AB
Oorsprong van het eerstegraads netwerk van Samuel Svensson
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Neogap Therapeutics AB
 Neogap Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Neogap Therapeutics AB is a Swedish clinical stage biopharmaceutical company. The private company is based in Stockholm, Sweden.
2
| Holding Company | Miscellaneous Commercial Services | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Samuel Svensson via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| CELGENE | Biotechnology | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Doctorate Degree | |
| University of Bergen | College/University | Corporate Officer/Principal | |
Aqilion AB
 Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Investment Managers | Chairman | |
| LIDDS AB | Pharmaceuticals: Major | Director/Board Member | |
Genagon Therapeutics AB
 Genagon Therapeutics AB BiotechnologyHealth Technology Genagon Therapeutics AB engages in the provision of scientific and technical research and development services. It develops and commercializes pharmaceuticals and medical products. The company was founded by Johan Erik Simon Fredriksson and Olof Andries Blokzijl on June 5, 2015 and is headquartered in Stockholm, Sweden. | Biotechnology | Director/Board Member | |
| Tcer AB | Director/Board Member | ||
Pelago Bioscience AB
 Pelago Bioscience AB Miscellaneous Commercial ServicesCommercial Services Pelago Bioscience AB is a specialized CRO that focuses on their patented cetsa® technology. The private company is based in Solna, Sweden. The technology can be applied throughout all steps of the drug discovery value chain. Pelago Bioscience provides bespoke projects in a wide range of services. The Swedish company's cetsa® navigate enables rapid target engagement confirmation, cetsa® navigate ht is for efficient high-throughput discovery, and cetsa® explore is a mass spectrometry-based approach allowing unbiased proteome-wide investigation. The Pelago Knowledge Center is a collection of resources used to drive innovation in drug discovery focusing on excellence in target engagement. | Miscellaneous Commercial Services | Director/Board Member | |
| OLINK HOLDING AB | Biotechnology | Director/Board Member | |
| Kynexis Medicine Development AB | Chief Executive Officer | ||
| J Lund & Associates, LLC | Corporate Officer/Principal | ||
| Harden Pharmacy LLC | Founder |
Statistieken
Internationaal
| Zweden | 10 |
| Verenigde Staten | 5 |
| Noorwegen | 2 |
Sectoraal
| Health Technology | 6 |
| Commercial Services | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Operationeel
| Corporate Officer/Principal | 6 |
| Director/Board Member | 5 |
| Founder | 3 |
| Independent Dir/Board Member | 2 |
| Chairman | 2 |
Sterkste connecties
| Insiders | |
|---|---|
| Johan Lund | 15 |
| Hans Grönlund | 1 |
- Beurs
- Insiders
- Samuel Svensson
- Bedrijfsconnecties
